Liver Lineup: Closing the Gap in Women’s Liver Health

In this episode of Liver Lineup, hosts Nancy Reau, MD, and Kimberly Brown, MD, are joined by Meena Bansal, MD, to examine how liver disease uniquely affects women across the lifespan. While conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) are often discussed in broad terms, the trio highlights how risk, progression, and outcomes can differ significantly based on sex and hormonal status. From reproductive years through menopause and beyond, physiologic changes play a central role in shaping liver health, but these distinctions have historically been underrecognized in both research and clinical care.Key Episode Timestamps0:00:00 – Welcome & women’s liver health framework0:03:17 – Menopause, estrogen loss, and fibrosis risk0:10:57 – PCOS, young women, and high‑risk metabolic phenotypes0:13:54 – Pregnancy, MASH, and maternal-fetal outcomes0:18:45 – Screening strategy, menopause as a pivot, and intervals0:28:03 – Practical toolkit: FIB‑4, second‑line tests, and who to test0:31:27 – Management, GLP‑1s, resmetirom, and key takeawayshttps://www.hcplive.com/view/liver-lineup-closing-the-gap-in-women-s-liver-health